# OnCo record getug-afu-16 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/getug-afu-16/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "getug-afu-16", "NCT00423475" ;
  schema:name "GETUG-AFU 16"@en ;
  schema:alternateName "GETUG-AFU 16"@en, "GETUG 16"@en ;
  schema:description "Adding six months of hormone therapy to radiotherapy given for a rising PSA after prostate surgery raised the proportion free of progression at ten years from about half to about two thirds."@en ;
  schema:url <https://onco.cc/trials/getug-afu-16/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00423475>, <https://doi.org/10.1016/S1470-2045(19)30486-3> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-bcr/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/goserelin/> ;
  onco:companies <https://onco.cc/companies/unicancer/> ;
  onco:terms <https://onco.cc/terms/adt/>, <https://onco.cc/terms/salvage-therapy/>, <https://onco.cc/terms/biochemical-recurrence/>, <https://onco.cc/terms/prostatectomy/> ;
  onco:trials <https://onco.cc/trials/rtog-9601/>, <https://onco.cc/trials/nct00567580/>, <https://onco.cc/trials/radicals-hd/> .